Latest News

01.23.20

The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial of Tepezza for Thyroid Eye Disease

Source: Horizon Therapeutics

01.22.20

Tangible Science Announces Timing for Tangible Boost Launch

Source: Tangible Science

01.22.20

Clearwave Launches New Patient Interface Solution

Source: Clearwave

01.22.20

FDA Approves First Treatment for Thyroid Eye Disease

Source: FDA

01.22.20

Alexander van der Mey Named New CCO at Optimo Medical AG

Source: Optimo Medical

01.21.20

Covenant Surgical Partners Rebrands Company, Announces Partnership With Texas Eye Care Network

Source: Covenant Physician Partners

01.21.20

Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis

Source: Aldeyra Therapeutics

01.21.20

AOA Receives Department of Justice Approval to Expand Group Purchasing Activities for Its AOAExcel Members

Source: VisionMonday

01.20.20

Study Finds Fewer Than Half of US Clinical Trials Complied With New Regulations on Reporting Results

Source: FirstWord

01.17.20

The Vision Council Notes That U.S.-China Trade Agreement Will Result in Tariff Reductions on Certain Optical Products

Source: VisionMonday

View more stories